Global Mechanisms to Improve Affordability of High-Priced Medicines: The Role of the WHO Model Lists of Essential Medicines
← Back to topic
Authors: Kristina Jenei
Year: 2026
Journal: Journal of Pharmaceutical Policy and Practice
DOI: 10.1080/20523211.2025.2601935
Keywords: essential medicines, WHO, pharmaceutical pricing, affordability, health policy
Abstract
Examines how WHO Essential Medicines List can improve affordability of high-priced medicines through voluntary licenses, pooled procurement, price transparency, and political advocacy mechanisms.
Cite this paper
bibtex
@misc{whoessentialmedicinesaffordability2026,
title = {Global Mechanisms to Improve Affordability of High-Priced Medicines: The Role of the WHO Model Lists of Essential Medicines},
author = {Kristina Jenei},
year = {2026},
journal = {Journal of Pharmaceutical Policy and Practice},
doi = {10.1080/20523211.2025.2601935},
url = {https://doi.org/10.1080/20523211.2025.2601935},
}